Skip to main content

Pharming Celebrates International Day of Women and Girls in Science - February 11

Other updates

On February 11, Pharming celebrates the International Day of Women and Girls in Science, which was first declared by the United Nations in 2015 to promote the full and equal access to, and participation of, women and girls in Science, Technology, Engineering and Mathematics (STEM) fields. The day promotes the role of women in scientific fields, promoting those already successful in the field, and aims to inspire more women and girls to pursue careers in science.

Read more

Pharming Group provides updates on EMA regulatory review of leniolisib MAA and plans to file for UK regulatory approval

Corporate updates

Pharming Group N.V. announces that it has received a Day 180 Second List of Outstanding Issues (LoOI) from the European Medicines Agency’s (EMA) Committee for Human Medicinal Products (CHMP) regarding its Marketing Authorisation Application (MAA) for leniolisib for adult and pediatric patients 12 years of age and older with APDS, a rare primary immunodeficiency. Based on the timetable included in the CHMP Day 180 Second LoOI, and considering the CHMP’s decision to reschedule the Ad-Hoc Expert Group (AEG) meeting to the end of November, Pharming now expects the CHMP to issue its opinion on the leniolisib MAA in the first quarter of 2024.

Read more

Pharming Group announces presentations at International Primary Immunodeficiencies Congress and the American College of Allergy, Asthma & Immunology Annual Scientific Meeting

Conference attendance

Pharming Group N.V. announces 14 poster presentations by the Company or its collaborators regarding leniolisib and RUCONEST® at the International Primary Immunodeficiencies Congress (IPIC) and the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting in November.

Read more

Filters

  • Cookies: This website uses cookies Check the cookies page for more information Accept Decline